Cargando…
External beam radiotherapy synergizes (188)Re-liposome against human esophageal cancer xenograft and modulates (188)Re-liposome pharmacokinetics
External beam radiotherapy (EBRT) treats gross tumors and local microscopic diseases. Radionuclide therapy by radioisotopes can eradicate tumors systemically. Rhenium 188 ((188)Re)-liposome, a nanoparticle undergoing clinical trials, emits gamma rays for imaging validation and beta rays for therapy,...
Autores principales: | Chang, Chih-Hsien, Liu, Shin-Yi, Chi, Chih-Wen, Yu, Hsiang-Lin, Chang, Tsui-Jung, Tsai, Tung-Hu, Lee, Te-Wei, Chen, Yu-Jen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4447003/ https://www.ncbi.nlm.nih.gov/pubmed/26056445 http://dx.doi.org/10.2147/IJN.S80302 |
Ejemplares similares
-
Translating Research for the Radiotheranostics of Nanotargeted (188)Re-Liposome
por: Chang, Chih-Hsien, et al.
Publicado: (2021) -
Biodistribution and pharmacokinetics of (188)Re-liposomes and their comparative therapeutic efficacy with 5-fluorouracil in C26 colonic peritoneal carcinomatosis mice
por: Tsai, Chia-Che, et al.
Publicado: (2011) -
A phase 0 study of the pharmacokinetics, biodistribution, and dosimetry of (188)Re-liposome in patients with metastatic tumors
por: Wang, Shyh-Jen, et al.
Publicado: (2019) -
Bi-Functional Radiotheranostics of (188)Re-Liposome-Fcy-hEGF for Radio- and Chemo-Therapy of EGFR-Overexpressing Cancer Cells
por: Huang, Yi-Shu, et al.
Publicado: (2021) -
(188)Re-Liposome Can Induce Mitochondrial Autophagy and Reverse Drug Resistance for Ovarian Cancer: From Bench Evidence to Preliminary Clinical Proof-of-Concept
por: Chang, Chia-Ming, et al.
Publicado: (2017)